-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Harpoon Therapeutics, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q1 2018 to Q3 2023.
- Harpoon Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending September 30, 2023 was $4.45M, a 67.3% decline year-over-year.
- Harpoon Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending September 30, 2023 was $37.3M, a 16.1% increase year-over-year.
- Harpoon Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $31.9M, a 34.9% increase from 2021.
- Harpoon Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $23.7M, a 35.6% increase from 2020.
- Harpoon Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2020 was $17.4M, a 202% increase from 2019.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)